Acelrx Pharmaceutica (ACRX) — Trending Stock Buzzer

Eye-Catching Shares: AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)

Equity Research Analyst's Stock Ratings: AcelRx Pharmaceuticals, Inc. (ACRX), Coupa Software Incorporated (COUP)

The overall volume in the last trading session was 6,573,938 shares. The stock rose 0.51% or $0.15 reaching $29.5 per share. About 930,082 shares traded. Caesarstone Ltd (NASDAQ:CSTE) has risen 6.39% since October 11, 2016 and is uptrending. It has outperformed by 1.77% the S&P500. The value of the total investment in AcelRx Pharmaceuticals, Inc. went from $44,000 to $38,000 a change of 13.6% quarter to quarter. With 916,200 shares average volume, it will take short sellers 4 days to cover their ACRX's short positions. Meeder Asset Mgmt reported 1,673 shares. D E Shaw & Incorporated has invested 0% in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX).

Focusing on some other company information, we can see that AcelRx Pharmaceuticals, Inc.

Multiple company employees have indulged in significant insider trading.

CEO, Angotti Vincent J., purchased 15,000 common shares of AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals is a specialty pharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The company has a market cap of $251.18 Million. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain. It now has negative earnings. Its lead product candidates include ARX-04 and Zalviso, which utilizes sublingual sufentanil, delivered through a non-invasive route of administration. Therefore 75% are positive.

Several analysts have released their opinion on AcelRx Pharmaceuticals, Inc. The stock is a Buy among 6 brokerage firms polled by Factset Research. Usually the RSI is considered overbought when above 70 and oversold when less than 30. The third largest holder is Palo Alto Investors, Llc, which now holds $5.37 million worth of this stock and that ownership represents almost 2.08% of its market capitalization.

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)'s institutional ownership stands at 39.70%. The firm has "Buy" rating by TH Capital given on Thursday, September 15. Creative Planning expanded its ownership by buying 3,600 shares an increase of 25.5% in the quarter. On Friday, August 4 the stock rating was maintained by H.C. Wainwright with "Buy". The firm has "Overweight" rating given on Tuesday, October 13 by Barclays Capital.

Anadarko Petroleum Corporation (APC) Shares Sold by California State Teachers Retirement System
Mitsubishi UFJ Trust & Banking Corp increased its stake in shares of Anadarko Petroleum Corporation by 1.6% in the second quarter. It dropped, as 60 investors sold HES shares while 154 reduced holdings. 159 funds opened positions while 684 raised stakes.

Investors sentiment decreased to 0.75 in 2017 Q2. Its down 0.25, from 1 in 2017Q1. Blackrock accumulated 650,347 shares.

The company is so far trading up by 5.77% percent from yesterday's close. Comparatively, ACRX posted earnings of $-0.22 per share in the same quarter, a year earlier. The stock traded on unusually build up volume of 3.14 Million comparing to the average volume of 1628.20 shares, completing picture of exact trends with uncompleted dots in volume over the norm. Bridgeway Mngmt reported 319,150 shares. Barclays Plc reported 133,590 shares. Hawk Ridge Management Llc acquired 61,000 shares as Caesarstone Ltd (CSTE)'s stock rose 15.69%. The consensus recommendation for stock is 2.20. At present, 0 analysts call it Sell, while 2 think it is Hold. A total number of 6 analysts provided estimations over revenues.

Beta is also an important valuation ratio for analyzing the stock of the company, ACRX's beta remains at 3.02. The rating was initiated by Berenberg with "Sell" on Monday, October 3. The stock of Emerson Electric Co.

Investors sentiment increased to 1 in 2017 Q2. There were 19 sold out positions, amounting to 615,954 shares. 86 funds opened positions while 383 raised stakes. (NYSE:EMR). Stephens Inc Ar owns 72,072 shares for 0.15% of their portfolio. Monetary Mgmt Group reported 5,030 shares.

Analysts were optimistic about the approval of AcelRx's Dsuvia, considering its limited abuse potential as well as the regulator's decision to not hold an advisory committee meeting. Longview Ptnrs (Guernsey) holds 12.62M shares. Haverford Tru has invested 0.05% in Emerson Electric Co. The insider now directly owns 120,000 shares worth $660,000.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Latest News